# Midwest Biomedical Accelerator Consortium: MBArC

> **NIH NIH U01** · UNIVERSITY OF MISSOURI-COLUMBIA · 2021 · $351,108

## Abstract

The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system,
termed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic
COVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The
proposed OE-HCCR-MOF based E-nose sensor is a novel biosensing and chemical sensing technology that
will fundamentally advance E-nose sensing technologies due to the improved sensitivity and selectivity.

## Key facts

- **NIH application ID:** 10312631
- **Project number:** 3U01HL152410-02S2
- **Recipient organization:** UNIVERSITY OF MISSOURI-COLUMBIA
- **Principal Investigator:** William P Fay
- **Activity code:** U01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $351,108
- **Award type:** 3
- **Project period:** 2020-12-21 → 2023-11-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10312631

## Citation

> US National Institutes of Health, RePORTER application 10312631, Midwest Biomedical Accelerator Consortium: MBArC (3U01HL152410-02S2). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10312631. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*